DK2902409T3 - Fremgangsmåde til fjernelse af endotoxin fra proteiner - Google Patents

Fremgangsmåde til fjernelse af endotoxin fra proteiner Download PDF

Info

Publication number
DK2902409T3
DK2902409T3 DK15156532.2T DK15156532T DK2902409T3 DK 2902409 T3 DK2902409 T3 DK 2902409T3 DK 15156532 T DK15156532 T DK 15156532T DK 2902409 T3 DK2902409 T3 DK 2902409T3
Authority
DK
Denmark
Prior art keywords
endotoxin
lactoferrin
protein
product
wound
Prior art date
Application number
DK15156532.2T
Other languages
English (en)
Inventor
Loren Ward
Kevin Thomson
Stan Wrobel
Vincent Anita Lind
Original Assignee
Glanbia Nutritionals Ireland Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40229071&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2902409(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glanbia Nutritionals Ireland Ltd filed Critical Glanbia Nutritionals Ireland Ltd
Application granted granted Critical
Publication of DK2902409T3 publication Critical patent/DK2902409T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/26Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • B01D15/361Ion-exchange
    • B01D15/362Cation-exchange
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40Transferrins, e.g. lactoferrins, ovotransferrins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/18Ion-exchange chromatography
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/36Extraction; Separation; Purification by a combination of two or more processes of different types
DK15156532.2T 2007-07-10 2008-07-10 Fremgangsmåde til fjernelse af endotoxin fra proteiner DK2902409T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94883907P 2007-07-10 2007-07-10
EP08826178.9A EP2173770B1 (en) 2007-07-10 2008-07-10 Method for removing endotoxin from proteins

Publications (1)

Publication Number Publication Date
DK2902409T3 true DK2902409T3 (da) 2018-04-16

Family

ID=40229071

Family Applications (2)

Application Number Title Priority Date Filing Date
DK15156532.2T DK2902409T3 (da) 2007-07-10 2008-07-10 Fremgangsmåde til fjernelse af endotoxin fra proteiner
DK08826178.9T DK2173770T3 (da) 2007-07-10 2008-07-10 Fremgangsmåde til fjernelse af endotoxin fra proteiner

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK08826178.9T DK2173770T3 (da) 2007-07-10 2008-07-10 Fremgangsmåde til fjernelse af endotoxin fra proteiner

Country Status (10)

Country Link
US (4) US7919589B2 (da)
EP (3) EP2173770B1 (da)
JP (2) JP2010533201A (da)
AU (1) AU2008274969B2 (da)
CA (1) CA2696145C (da)
DK (2) DK2902409T3 (da)
ES (1) ES2518290T3 (da)
NZ (1) NZ583234A (da)
PL (1) PL2650302T3 (da)
WO (1) WO2009009706A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2391225B1 (en) * 2009-01-28 2020-05-06 Jean-Paul Perraudin Method for production of lactoferrin
FR2941374B1 (fr) * 2009-01-28 2011-03-11 Alaxia Utilisation d'une association synergique d'ions hypothiocyanites et/ou hypohalites et de lactoferrine pour la preparation pour le traitement de la mucoviscidose
AU2010239795B2 (en) 2009-04-24 2014-07-10 Westland Co-Operative Dairy Company Limited Method of preparing low-iron lactoferrin
US10448889B2 (en) * 2011-04-29 2019-10-22 Medtronic, Inc. Determining nerve location relative to electrodes
US9358256B2 (en) 2013-07-11 2016-06-07 Links Medical Products, Inc. Gap-patterned foam dressing and method of making same
US20170224268A1 (en) * 2016-02-10 2017-08-10 Bloom Technologies NV Systems and methods for detecting a labor condition
FR3115037A1 (fr) 2020-10-12 2022-04-15 Compagnie Laitiere Europeenne Procédé de purification de fraction de protéines cationiques et fraction ainsi obtenue

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1563100A (en) 1975-11-26 1980-03-19 Atomic Energy Authority Uk Separation of macromolecules
FR2505615A1 (fr) 1981-05-15 1982-11-19 Elf Aquitaine Procede d'extraction de lactoferrine et d'immunoglobulines du lait
JPS61145200A (ja) 1984-12-19 1986-07-02 Snow Brand Milk Prod Co Ltd ウシラクトフェリンの分離精製法
BE901672A (fr) 1985-02-07 1985-08-07 Oleofina Sa Procede de purification de proteines du lait et de ses derives.
IE61701B1 (en) 1986-07-17 1994-11-30 Morinaga Milk Industry Co Ltd Process for producing bovine lactoferrin in high purity
JPH0725800B2 (ja) 1987-04-10 1995-03-22 雪印乳業株式会社 硫酸エステル化物を用いて乳からラクトフエリンを分離、精製する方法
SE458818B (sv) 1987-11-27 1989-05-16 Svenska Mejeriernas Riksforeni Foerfarande foer utvinning av rena fraktioner av laktoperoxidas och laktoferrin ur mjoelkserum
NZ230031A (en) 1988-07-27 1991-10-25 Snow Brand Milk Products Co Ltd Separation of proteins (e.g. lactoferrin) using affinity gel carrier in a rotary column
US5169936A (en) 1989-04-14 1992-12-08 Biogen, Inc. Protein purification on immobilized metal affinity resins effected by elution using a weak ligand
US6066469A (en) 1990-03-08 2000-05-23 Ferro Dynamics, Inc. Cloning, expression, and uses of human lactoferrin
JP2974434B2 (ja) 1990-03-15 1999-11-10 雪印乳業株式会社 分泌性コンポネント含有組成物
ATE129125T1 (de) 1992-01-15 1995-11-15 Campina Melkunie Bv Verfahren zur isolierung von lactoferrin und lactoperoxidase aus milch und milchprodukten.
JPH05202098A (ja) * 1992-01-29 1993-08-10 Snow Brand Milk Prod Co Ltd 乳質原料から生理活性物質の製造法
ZA932568B (en) 1992-04-24 1993-11-12 Baylor College Midecine A Non Production of recombinant human lactoferrin
US5756680A (en) 1994-01-05 1998-05-26 Sepragen Corporation Sequential separation of whey proteins and formulations thereof
US6096870A (en) 1994-01-05 2000-08-01 Sepragen Corporation Sequential separation of whey
AU1809895A (en) * 1994-02-16 1995-09-04 Pharming Bv Isolation of lactoferrin from milk
US6268487B1 (en) 1996-05-13 2001-07-31 Genzyme Transgenics Corporation Purification of biologically active peptides from milk
NL1005677C2 (nl) 1997-03-27 1998-09-29 Campina Melkunie Bv Werkwijze voor het winnen van groeifactoren, of een samenstelling die één of meer groeifactoren bevat, uit melk of een derivaat daarvan.
US6172040B1 (en) 1999-05-28 2001-01-09 A. Satyanarayan Naidu Immobilized lactoferrin antimicrobial agents and the use thereof
KR100356738B1 (ko) * 2000-09-07 2002-10-18 주식회사 삼양제넥스 염기성 단백질로부터 엔도톡신을 제거하는 방법
US20030191193A1 (en) 2002-04-03 2003-10-09 Jillian Cornish Lactoferrin
WO2005003152A1 (en) * 2003-06-24 2005-01-13 Akzo Nobel N.V. Removal of lipopolysacchrarides from protein- lipopolysaccharide complexes by nonflammable solvents
US7125963B2 (en) 2004-03-03 2006-10-24 En N Tech Inc Treatments for contaminant reduction in lactoferrin preparations and lactoferrin containing compositions
US7183381B2 (en) * 2004-10-26 2007-02-27 Agennix, Inc. Composition of lactoferrin related peptides and uses thereof
FR2889068B1 (fr) * 2005-07-29 2012-03-02 Cie Laitiere Europeenne Nouvelles fractions proteiques laitieres et leur utilisation pour la prevention ou le traitement des maladies inflammatoires chroniques
ES2526640T3 (es) * 2005-11-18 2015-01-14 Glanbia Nutritionals (Ireland) Limited Composiciones para romper e inhibir la reconstitución de la biopelícula de heridas

Also Published As

Publication number Publication date
DK2173770T3 (da) 2015-06-08
WO2009009706A1 (en) 2009-01-15
EP2902409A1 (en) 2015-08-05
ES2518290T3 (es) 2014-11-04
EP2650302B1 (en) 2014-10-08
EP2902409B1 (en) 2018-01-17
EP2173770A4 (en) 2010-09-08
US8138150B2 (en) 2012-03-20
US20130035477A1 (en) 2013-02-07
JP2010533201A (ja) 2010-10-21
AU2008274969A1 (en) 2009-01-15
US8778662B2 (en) 2014-07-15
US7919589B2 (en) 2011-04-05
EP2173770B1 (en) 2015-05-27
US20090029921A1 (en) 2009-01-29
JP5989723B2 (ja) 2016-09-07
US9738882B2 (en) 2017-08-22
CA2696145A1 (en) 2009-01-15
NZ583234A (en) 2012-06-29
AU2008274969B2 (en) 2014-04-24
CA2696145C (en) 2016-12-20
US20120028882A1 (en) 2012-02-02
US20140322797A1 (en) 2014-10-30
JP2015017098A (ja) 2015-01-29
EP2173770A1 (en) 2010-04-14
PL2650302T3 (pl) 2015-01-30
EP2650302A1 (en) 2013-10-16

Similar Documents

Publication Publication Date Title
US9738882B2 (en) Method for removing endotoxin from proteins
JP2002020402A (ja) 溶解鉄への選択的結合性を示す固体組成物
CN107988192A (zh) 用于纯化重组adamts13和其它蛋白质的方法以及其组合物
US20200121846A1 (en) Apparatus for the extracorporeal treatment of blood
JP6876655B2 (ja) タンパク質の精製方法
KR20100058520A (ko) 인자 Ⅷ 및 폰 빌리브란트 인자(vWF)의 정제 방법
AU2014201943B2 (en) Method for removing endotoxin from proteins
EP3411384B1 (en) Extraction process from colostrum
CN116322920A (zh) 使用氧化硅吸附从血浆中纯化fviii
JPH07155194A (ja) タンパク質の精製法
JP2001170501A (ja) 乳清からのラクトフェリンアイソフォームの分離方法
CN1557494A (zh) 抗微生物生物活性物质的制备及应用
WO2021262041A1 (ru) Способ получения высокоочищенного рекомбинантного ингибитора с1-эстеразы человека
PL221015B1 (pl) Sposób otrzymywania inhibitorów cysteinowych peptydaz o czystości elektroforetycznej z materiałów biologicznych
JPH05170799A (ja) ヒトインターロイキン8の精製方法
CN103122346A (zh) 重组klk14蛋白的纯化方法
JPS5841823A (ja) 尿の保存方法
UA57689C2 (en) Method for producing substance of insulin suitable for immediate release dosage form